Zacks Small Cap Research on MSN
AINMF: Company encouraged by rising interest in leveraging AI to improve & derisk clinical trial activity
By M. Marin OTCQB: AINMF READ THE FULL AINMF RESEARCH REPORT AINMF believes platform is well-positioned, as use of AI in clinical development is expected to rise NetraMark (OTCQB: AINMF), an AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results